Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to oleic acid intended to replace saturated fatty acids (SFAs) in foods or diets and maintenance of normal blood LDL-cholesterol concentrations and maintenance of normal (fasting) blood concentrations of triglycerides. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The foods/food constituents that are the subject of the health claims are “monounsaturated fatty acids (mainly oleic acid)”, “oleic acid” and “extravirgin olive oil”. This opinion applies to the replacement of mixtures of SFAs as present in foods or diets with oleic acid. The Panel considers that the food constituent, oleic acid intended to replace saturated fatty acids (SFAs) in foods or diets, which is the subject of the health claims, is sufficiently characterised.
Scientific Opinion on the substantiation of health claims related to oleic acid intended to replace saturated fatty acids (SFAs) in foods or diets and maintenance of normal blood LDL-cholesterol concentrations (ID 673, 728, 729, 1302, 4334) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 673, 4334) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 / C.V. Agostoni, J.L. Bresson, S. Fairweather Tait, A. Flynn, I. Golly, H. Korhonen, P. Lagiou, M. Løvik, R. Marchelli, A. Martin, B. Moseley, M. Neuhäuser Berthold, H. Przyrembel, S. Salminen, Y. Sanz, S. Strain, S. Strobel, I. Tetens, D. Tomé, H. van Loveren, H. Verhagen. - In: EFSA JOURNAL. - ISSN 1831-4732. - 9:4(2011), pp. 2043-2043. [10.2903/j.efsa.2011.2043]
Scientific Opinion on the substantiation of health claims related to oleic acid intended to replace saturated fatty acids (SFAs) in foods or diets and maintenance of normal blood LDL-cholesterol concentrations (ID 673, 728, 729, 1302, 4334) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 673, 4334) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
C.V. AgostoniPrimo
;
2011
Abstract
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to oleic acid intended to replace saturated fatty acids (SFAs) in foods or diets and maintenance of normal blood LDL-cholesterol concentrations and maintenance of normal (fasting) blood concentrations of triglycerides. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The foods/food constituents that are the subject of the health claims are “monounsaturated fatty acids (mainly oleic acid)”, “oleic acid” and “extravirgin olive oil”. This opinion applies to the replacement of mixtures of SFAs as present in foods or diets with oleic acid. The Panel considers that the food constituent, oleic acid intended to replace saturated fatty acids (SFAs) in foods or diets, which is the subject of the health claims, is sufficiently characterised.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
